IL17A and pulmonary emphysema: When we treated the animals with an anti-IL-17 antibody, we observed control and reduction of AHR, as well as lower Raw, Ers, total cell counts in the BALF, eosinophilic and neutrophilic inflammation, and mean linear intercept, which is a marker of pulmonary emphysema.